Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dina S. Ghallab"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-17 (2022)
Abstract Marine algae have served as a treasure trove of structurally variable and biologically active metabolites. The present study emphasizes on UPLC–MS metabolites fingerprinting for the first systematic broad scale metabolites characterization
Externí odkaz:
https://doaj.org/article/f3027b225ee74c58948bca4432642153
Autor:
Dina S. Ghallab, Eman Shawky, Ali M. Metwally, Ismail Celik, Reham S. Ibrahim, Mohamed M. Mohyeldin
© The Royal Society of Chemistry.Xanthine oxidase (XO) has been well-recognized as a validated target for the treatment of hyperuricemia and gout. Currently, there are two drugs in clinical use that shut down XO overactivity, allopurinol and febuxos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a81fda0d87c1c907f09a4e4f375c2b8a
https://avesis.erciyes.edu.tr/publication/details/ad661e68-48eb-4ba2-968a-7f887a6d1f11/oai
https://avesis.erciyes.edu.tr/publication/details/ad661e68-48eb-4ba2-968a-7f887a6d1f11/oai
Autor:
Dina S. Ghallab, Eman Shawky, Doaa A. Ghareeb, Shaymaa A. Abdulmalek, Soad M. Mohy El-Din, Mohamed M. Mohyeldin, Reham S. Ibrahim
Publikováno v:
Food Bioscience. 50:102091
Autor:
Dina S, Ghallab, Eman, Shawky, Ali M, Metwally, Ismail, Celik, Reham S, Ibrahim, Mohamed M, Mohyeldin
Publikováno v:
RSC advances. 12(5)
Xanthine oxidase (XO) has been well-recognized as a validated target for the treatment of hyperuricemia and gout. Currently, there are two drugs in clinical use that shut down XO overactivity, allopurinol and febuxostat; however, detrimental side eff
Publikováno v:
LWT. 136:110298
In the current study, propolis samples from various geographical localities in Egypt were investigated by chemical profiling and xanthine oxidase (XO) inhibitory and radical scavenging activity testing. Metabolic fingerprints were attained using ultr
Autor:
Ghallab, Dina S.1 (AUTHOR), Shawky, Eman1 (AUTHOR) eman.m.shawky@alexu.edu.eg, Ibrahim, Reham S.1 (AUTHOR), Mohyeldin, Mohamed M.1 (AUTHOR)
Publikováno v:
Scientific Reports. 5/16/2022, Vol. 12 Issue 1, p1-17. 17p.
Publikováno v:
Diabetes Week; 9/2/2024, p177-177, 1p
Autor:
Ghallab, Dina S., Shawky, Eman, Metwally, Ali M., Celik, Ismail, Ibrahim, Reham S., Mohyeldin, Mohamed M.
Publikováno v:
RSC Advances; 2022, Vol. 12 Issue 4, p2843-2872, 30p
Publikováno v:
Drug Week; 6/7/2024, p2561-2561, 1p